INTEGRATED ORAL HEALTH CARE
Dr Ajesh George, Professor of Interprofessional Oral Health, School of Nursing and Midwifery, Western Sydney University (WSU) & Director and Co-Founder, Australian Centre for Integration of Oral Health
RESEARCHER PROFILE
Filmed in Sydney, Australia | August 2025
Dr Ajesh George is a Professor of Interprofessional Oral Health in the School of Nursing and Midwifery, Western Sydney University (WSU) and Honorary Professor in the School of Dentistry at The University of Sydney. He is a dentist with extensive experience in integrated oral health care and is a renowned expert globally in providing oral health training to non-dental professionals and translating oral health guidelines into their practice. Dr George is also the Director and Co-founder of the “Australian Centre for Integration of Oral Health” (ACIOH) which is a leading national research centre led by WSU in collaboration with various partners including universities, health services and professional organisations.
Over the last decade Dr George has been coordinating multidisciplinary teams in implementing effective and sustainable models of care across the lifespan and his work has been recognised by key bodies including the World Health Organisation. He has also been instrumental in training nurses and midwives to promote oral health by integrating oral health into undergraduate courses at Australian Universities as well as developing nationally recognised oral health professional development training programs.
Prof George has over $5.4M in funding including NHMRC grants, more than 150 publications (90% Q1/Q2 journals), 175 conference presentations (40 international), 19 research awards and a H-index of 34 with 4367 citations. He has 13 PhD and Masters completions and currently supervises 11 HDR students most of whom have received scholarships. In 2021 and 2024 Prof George was recognised as one of the top 2% scientists worldwide
Source: Supplied
-
Funding the best brains to beat brain cancer
The Charlie Teo Foundation is dedicated to funding and advancing research into brain cancer, with a particular focus on developing more effective treatments and finding a cure for this devastating disease.
Since its inception, the foundation has committed nearly $15 million to brain cancer research, funding notable projects in Australia and the United States. These projects explore innovative approaches to understand and treat brain cancer more effectively, with a focus on translating findings from animal studies to human applications. Charlie’s dedication to finding solutions for this devastating disease remains unwavering as he travels frequently to collaborate with global researchers. -
Biostatistics in Clinical Trials
As a biostatistician working in research and clinical settings, Kate Francis plays a vital role in ensuring all projects adhere to best practice guidelines and are transparently reported. She has served as the lead statistician for the analysis of clinical trials across a broad range of subject areas, including neonatal resuscitation, BCG for allergy and infection, convulsive status epilepticus and her work has been published in the top journals such as The New England Journal of Medicine, JAMA, and The Lancet. Most recently she was awarded the 2025 Excellence in Trial Statistics Award for her work on the PLUSS trial.
-
Investigating invasive lobular carcinoma and metaplastic breast cancer sub-types
Assoc Prof McCart Reed is the scientific lead on an MRFF-funded (Medical Research Future Fund) genomics program investigating the potential for the application of Whole Genome Sequencing in the breast cancer care pathway in Australia, ‘Q-IMPROvE’. She applies genomics and spatial transcriptomics methodologies to archival clinical samples to understand the differences between tumour types and their potential for treatment. Amy is passionate about clinical research, biobanking and precision oncology. In addition to her breast cancer research portfolio, she is on the steering committee for the Brisbane Breast Bank and the Scientific Advisory Board for Breast Cancer Trials.
